Aberdeen Asset Management’s Pediatrix Medical MD Stock Holding History

Aberdeen Asset Management’s Portfolio MD Stock Details MD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-48,026	Closed	-$3.48M	–	741
2016 Q2	$3.48M	Sell	48,026 -955	-2%	-$65.7K	0.01%	484
2016 Q1	$3.17M	Sell	48,981 -49,069	-50%	-$3.26M	0.01%	492
2015 Q4	$7.38M	Buy	98,050 +2,303	+2%	+$170K	0.03%	351
2015 Q3	$7.35M	Hold	95,747	–	–	0.03%	314
2015 Q2	$7.1M	Sell	95,747 -2,451	-2%	-$176K	0.02%	334
2015 Q1	$7.12M	Sell	98,198 -108,576	-53%	-$7.55M	0.02%	312
2014 Q4	$13.7M	Sell	206,774 -114,677	-36%	-$7M	0.03%	225
2014 Q3	$17.6M	Sell	321,451 -122,959	-28%	-$6.98M	0.04%	231
2014 Q2	$25.8M	Buy	+444,410	New	+$26.1M	0.05%	193

Other funds holding MD

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return

WCM

Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return

Aberdeen Asset Management's MD Position: Q3 2016 in Review

Aberdeen Asset Management sold out of Pediatrix Medical (MD) in Q3 2016, closing a stake of 48,026 shares — an estimated $3.48M sold.

Aberdeen Asset Management first reported a position in MD in Q2 2014 and held it in 9 quarters. The position peaked at $25.8M in Q2 2014. 381 funds tracked by Wall St. Rank hold MD as of Q3 2016.

Aberdeen Asset Management reported no remaining Pediatrix Medical position as of Q3 2016 after selling out during the quarter.
Aberdeen Asset Management sold 48,026 Pediatrix Medical shares in Q3 2016, an estimated $3.48M.
Aberdeen Asset Management first reported a position in Pediatrix Medical in Q2 2014 and held it in 9 quarters.
Aberdeen Asset Management's Pediatrix Medical position peaked at $25.8M in Q2 2014.
381 funds tracked by Wall St. Rank held Pediatrix Medical as of Q3 2016.

Based on Aberdeen Asset Management's 13F filing for Q3 2016, filed 14 Nov 2016.